User Name Password Remember Me  
 
 
   
Video Podcast
Audio Cast
Mobile(WAP)
  Pedi Poll  
Is childhood obesity on the rise? Are children becoming fatter?
Yes
No
  Translate This Page  
 
MMR – VACCINE - LATEST UPDATES

In the recent years MMR vaccine has attracted few controversies regarding its safety profile.

  • MMR and Autism: There have been allegations by a small number of researchers that MMR is associated with autistic disorders in vaccinees, but recently many studies showed that there is no temporal relationship between MMR immunization and development of autism.
  • MMR and Inflammatory bowel diseases (IBD): Few studies proposed the epidemiological association of IBD and MMR vaccine or measles vaccine alone in view of following reasons:– Measles virus antigen was found in intestinal wall of some patients with IBD, few patients had higher concentration of serum measles IgM and in a few wild type measles virus was found in peripheral blood monocytes. To date available literature does not support an association between measles containing vaccines and risk of IBD.
  • MMR and Central Nervous system disorders: Few cases of aseptic meningitis, menings encephalitis and Gullian Barre Syndrome have been reported after MMR vaccination. But recent work from UK and South America do not support a causal association.
  • Hyper sensitivity reactions: MMR vaccine contains hydrolyzed gelatin as a stabilizer. So persons having history of an anaphylactic reaction to gelatin or gelatin containing products should be vaccinated with MMR with extreme caution.
  • Mumps antigen and the chances of aseptic meningitis: 3 cases of Aseptic meningitis were reported following use of Urabe MMR from Canada in 1987. The Urabe MMR was recalled from Canada in 1988. Urabe MMR was introduced in UK in 1987-88 and 1 case was reported in the pre-licensure study. The risk estimated varied from 1 in 10,000 to 1 in 100,000. Meanwhile similar cases were reported from Japan too. In 1991 active surveillance program started in UK. The risk of aseptic meningitis was estimated to be 1 in 143,000. This led to withdrawal of Urabe MMR in September 1992 and it was replaced by the JL strain MMR. The active surveillance continued and the risk was estimated to be 1 in 143,00 with Urabe and 1 in 227,000 with JL strain (p: 0.0096). This proves that the Jerryl Lynn strain is much safer. However the JL strain containing MMR vaccine is 3-4 times more costly than Urabe strain MMR. In west the Urabe strain is not used at all and most of the countries use JL strain. The JL strain containing MMR is available now in the Indian market. It may be worthwhile offering the same to those who can afford the extra cost, as it is definitely safer than the Urabe strain MMR. Incidentally aseptic meningitis is rarely reported following Urabe strain MMR from developing countries. This may be another reason for continued use of this vaccine in India.
IAP position on MMR vaccine: MMR should be promoted as a universal vaccine, and should be given between 15-18 months of age. It should also be given to all adolescent girls not previously immunized and hospital staff members likely to come in contact with pregnant mothers. There is no upper age limit for this vaccine.

References:

  1. Madsen KM, Vestergaard M. MMR Vaccination and Autism : What is the Evidence for a Causal Association?
  2. Patja A, Paunio M, Kinnunen E et al. Risk of Guillain-Barre syndrome after measles-mumps-rubella vaccination. J Pediatr 2001;138(2):250-4.
  3. Makela A, Nuorti JP, Peltola H. Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics. 2002;110(5):957-63.
  4. Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders Washington, DC: National Academies Press 2001.
Last Updated on 05-11-2004 Courtesy Pediatric Oncall

MMR VACCINE
Dr. Nitin Shah
Hon. Pediatrician- UHC, LTMG Hospital, Mumbai.
Treasurer, Indian Academy of Pediatrics, 1998-2001.

1 What is MMR vaccine given for?
1. MMR vaccine is given for protection against 3 common childhood viral diseases namely measles, mumps & rubella (German Measles).

2 How is MMR vaccine available?
2. MMR vaccine is available as a bulb containing lyophilized powder. Diluent is distilled water or normal saline & is available separately in an ampoule. MMR is a live viral vaccine. It is available as mono dose or as multidose bulb.

3.How is MMR stored?
3. It is stored in a refrigerator. The vaccine stocks are stored frozen in freezer compartment. Working stock can be stored at 2-8 degree C in the lower rack. No vaccine is stored in the door of the refrigerator. The diluent is also stored at 2-80C..

4 How is MMR vaccine prepared?
4. MMR vaccine is prepared by adding diluent in the powder. Once prepared it should be used immediately. At the most it can be kept for 2-3 hours that too at 2-8 degree C after which it is discarded. Like measles vaccine, MMR vaccine does not have preservative, hence growth of pathogens can occur after reconstitution. Such a vaccine if not stored properly or used beyond 2-3 hours of reconstitution can lead to toxic shock syndrome as seen with measles vaccine.

5 How is MMR vaccine given?
5. MMR vaccine is given subcutaneously using 26 no. needle, by raising a fold of skin with one hand & injecting the vaccine beneath it. It is given either over anterolateral aspect of thigh or over the arm. The efficacy of the vaccine remains the same even if given intramuscularly by mistake; gluteal region should not be used for any injection in children, especially below 2 years of age.

6 Why is MMR vaccine essential?
6. MMR vaccine is not an EPI vaccine as per Govt. of India. Indian Academy of Pediatrics & most of the pediatricians strongly recommend this vaccine as a routine for all children. There are some states in India (like Delhi) where pilot projects of giving MMR routinely as a part of EPI vaccines have been started. Hopefully it will become a part of national schedule soon. It is essential for children as the measles part of MMR will boost up the immunity against measles induced by previous measles vaccine. Mumps is a common cause of morbidity in children with occasional chances of complications like encephalitis & pancreatitis. But its most important silent complications are oopheritis & orchitis. This will manifest as primary sterility in adulthood. Rubella or German measles though a benign disease can lead to congenital rubella syndrome if it occurs during pregnancy. Such a child will have cataract, deafness, congenital heart disease, microcephaly, mental retardation, hepatitis & many other complications. Hence MMR vaccine is essential.

7 When is MMR vaccine given?
7. MMR vaccine has best efficacy when given beyond 12 months especially the mumps & the rubella part of it. If you wait till that age, measles can occur as it can occur after 9 months. Hence it is recommended to give measles vaccine at 9 months, which will protect early against measles followed by MMR vaccine at 15 months of age, which will act best against mumps & rubella & will act as a booster for measles. As the routine coverage of measles becomes higher the incidence of measles will drastically fall. At such times one can postpone the age for measles vaccine & can give straight MMR at 12 months as is done in western countries. (Also see Measles Vaccine)

8 Is there a need to give booster dose of MMR vaccine?
8. As of today there is no need to give booster dose of MMR vaccine in India. This is because the routine coverage by measles & MMR vaccine is poor. Therefore naturally occurring subclinical measles, mumps & rubella are common which act like natural booster in vaccinees. A time may come in coming years when the routine coverage of MMR will go up which will lead to drastic reduction in natural infections & hence decrease natural boosting against measles, mumps & rubella. This has been the experience in western countries. At such time a booster of MMR at 5 years (school entry) or 15 years (school exit) is recommended, as is practiced by USA.

9 What is the efficacy of MMR vaccine?
9. Single dose of MMR vaccine has excellent efficacy with> 95% protective titres, especially against measles & rubella. Breakthrough mumps can occur inspite of vaccination. A booster of MMR will further increase its efficacy as discussed before.

10.What are the side effects of MMR vaccine?
10. MMR vaccine is a very safe vaccine. If at all, it leads to mild pain, swelling, induration or fever. It is seen in less than 10% of patients, is transient & mild, lasts for <24 hours & responds well to paracetamol. It can occur from the day of injection till 5-7 days. Sometimes a patient can develop measles like infection with cough, cold, red eyes & rash over skin. Again it lasts for 2-5 days & is self-limiting. There are 2 complications that could prove fatal and are discussed in next question. Contrary to belief, MMR vaccine does not lead to SSPE. Again it is discussed later.

11.What are the complications of MMR vaccine?
11. Anaphylaxis is seen in patients with egg allergy as MMR (like measles vaccine) is grown in chick embryo culture. In patients, with mild egg allergy it leads to less severe reactions like angioedema, puffiness, urticaria, anaphylactoid reactions. In patients with severe allergies, it can lead to frank anaphylaxis. In cases of severe egg allergy, measles & MMR vaccines are contraindicated. In case with mild egg allergy, measles or MMR vaccines can be given but with strict medical supervision and all the measures of resuscitation & drugs kept ready should the patient develop reaction.
Toxic shock syndrome (TSS) is an unfortunate but avoidable reaction of MMR vaccine. MMR vaccine does not have a preservative. Hence, once reconstituted it should not be kept beyond 2-3 hours & that too it should be kept at 2-80C. If it is not stored properly or is used after 2-3 hours there are chances of growth of pathogens, most important being staphylococci. When this happens, the staphylococcal toxin formed will lead to fever, diarrhea, vomiting, blood in stools, DIC, shock & ultimately death. This usually follows use of multidose bulbs where the balance doses are not kept properly or not used in time. Obviously, it is totally avoidable by using properly stored vaccine and using the vaccine immediately after reconstitution. This is the reason why mono doses are preferred over multidose bulbs.

12. Can MMR vaccine lead to SSPE?
12. MMR like Measles Vaccine does not lead to SSPE but actually prevents SSPE. This is discussed in detail under ‘Measles Vaccine’.

13.What are the contraindications of MMR vaccine?
13. True & severe egg allergy is the contraindication to use Measles or MMR vaccine. A sick patient should receive any vaccine after he recovers from his illness. If a patient has shown severe adverse effects following any vaccine he should not receive the same vaccine again & this is true for measles & MMR vaccine too.

14.What if patient comes late for MMR vaccine?
14. Measles mostly occurs till 5 – 15 years of age. Mumps & rubella can occur at any age. Hence if a patient comes late he can be given MMR till 5-15 years of age after which MR (Mumps, Rubella) vaccine can be given. As MR vaccine is not available MMR can be given even to older individuals as no harm is done by measles part. If a patient has already developed measles, mumps & rubella he dose not need a vaccine against them.

15. Can MMR be given along with other vaccines?
15. Yes, MMR can be given simultaneously with other vaccines. In fact it can be given along with 1st booster dose of OPV, DPT vaccine & Hib or with Varicella vaccine. A combination vaccine containing MMR + varicella is available. Like with measles, MMR vaccine can lead to temporary suppression of immunity for 4-6 weeks. Hence BCG should not be given with MMR & no other vaccine should be given within 4-6 weeks of MMR vaccine.

Last created on 23-02-2001
Last updated on 01-12-2004

How to cite this url

Dr.Shah N.MMR vaccine Measles, Mumps and Rubella.Pediatric Oncall [serial online] 2004 [cited 2004 December 1];1. Available from:
http://www.pediatriconcall.com/fordoctor/diseasesandcondition/
immunization_vaccination/mmr_vaccine.asp
 
  Diseases  
Adolescent Pediatrics
Anogenital Disorders
Behavioral Pediatrics
General Pediatrics
Immunization & vaccines
Medical Procedures
Neonatology
Pediatric Allergies
Pediatrics Anesthesia
Pediatrics Cardiology
Pediatrics Dentistry
Pediatrics Emergencies
Pediatrics Endocrine
Pediatric ENT
Pediatrics Genetics
Pediatrics GI
Pediatrics Hematology
Pediatric Hepatobiliary
Pediatrics Infections
Pediatrics Nephrology
Pediatrics Neurology
Pediatric Nutrition
Pediatrics Oncology
Pediatrics Ophthalmology
Pediatrics Orthopedics
Pediatrics Radiology
Pediatric Rheumatology
Pediatric Surgery
Pediatric Dermatology
  Search  
Hospitals
Pediatrician
Special Schools
Medical Colleges
Pediatric Conferences
Jobs & Vacancies
Journals
  Ped Tools  
Pediatric Calculator
Drug Index
Medical Equipment
Vaccine Reminder
Adverse Drug Reactions
Biochemical Profile
 
 
Parent Corner l Kids Corner l Terms & Condition | Privacy Statement l Advertising l Feedback l Awards
About Us
l Link to Us l Site Map l Shopping Mall  
Partner Sites
 HIV in Children  Infection in Children  Pedcall  Medical ADRIS  Vaccine Reminder  Pediatric Oncall Journal

Copyright© 2000-2008 All rights reserved with Pediatric Oncall

Disclaimer:The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitue an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.

 
Sitemap For Doctor | Sitemap For Parent | Sitemap For Kids Site designed and maintained by Levioza